Gb Sciences (NASDAQ:GBLX) | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Home
Companies
Gb Sciences

BRIEF

published on 10/15/2024 at 13:05, 1 month 5 days ago

GB Sciences Secures Licensing Deal with EndoPure Life Sciences

Clinical Trials GB Sciences Licensing Deal EndoPure Parkinson's Treatment
BRIEF

published on 10/15/2024 at 13:05, 1 month 5 days ago

GB Sciences conclut un accord de licence avec EndoPure Life Sciences

Essais Cliniques Accord De Licence EndoPure Sciences GB Traitement De La Maladie De Parkinson
PRESS RELEASE

published on 10/15/2024 at 13:00, 1 month 5 days ago

GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug
EndoPure Life Sciences to finance first-in-human clinical trials for GB Sciences' cannabinoid-based products through exclusive licensing deal. Aging populations drive global demand for treatments of neurological disorders

Global Market Growth Neurological Disorders Endopure Life Sciences First-in-human Clinical Trials Cannabinoid-based Products
BRIEF

published on 07/02/2024 at 15:05, 4 months 18 days ago

GB Sciences Signs Licensing Deal with Endopure Life Sciences for Cannabinoid-Based Neurological Treatments

Neurological Disorders GB Sciences Endopure Life Sciences Cannabinoid-based Treatments Licensing Deal
BRIEF

published on 07/02/2024 at 15:05, 4 months 18 days ago

GB Sciences signe un accord de licence avec Endopure Life Sciences pour des traitements neurologiques à base de cannabinoïdes

Troubles Neurologiques Accord De Licence GB Sciences Sciences De La Vie Endopure Traitements À Base De Cannabinoïdes
PRESS RELEASE

published on 07/02/2024 at 15:00, 4 months 18 days ago

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences partners with Endopure Life Sciences for licensing deal on cannabinoid-based treatments for neurological disorders in Brazil and South America, addressing growing market demand

Neurological Disorders GB Sciences Endopure Life Sciences Cannabinoid-based Treatments Licensing Deal
PRESS RELEASE

published on 12/14/2023 at 13:00, 11 months 6 days ago

Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
PRESS RELEASE

published on 07/11/2023 at 13:00, 1 year 4 months ago

Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
PRESS RELEASE

published on 03/20/2023 at 12:00, 1 year 8 months ago

GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China
PRESS RELEASE

published on 03/07/2023 at 15:00, 1 year 8 months ago

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

Accesswire

Published on 11/21/2024 at 09:00, 52 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 17 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 27 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 52 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 52 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 11 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 51 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 52 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 52 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 37 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 45 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 32 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE